Chen et al. 2010 (cross-sectional) |
Bangladesh (Araihazar) HEALS, n = 11,319 ♂♀ |
Self-report prior to baseline |
1.11 (95% CI: 0.73, 1.69) adjOR |
176.2–864 (Q5) vs. 0.1–8 (Q1) µg As/L drinking water, CEI Cohort:
0.1–864 µg As/L |
Age, sex, BMI, smoking status, educational attainment |
Lai et al. 1994 (cross-sectional) |
Taiwan (southern) As-endemic region, n = 891 ♂♀ |
Self-report, OGTT, treatment history |
10.05 (95% CI: 1.3, 77.9) adjOR |
≥ 15 vs. 0 ppm-year drinking water, CEI Cohort: 780 (700–930) µg As/L;
median (range) concentrations in artesian wellsd |
Age, sex, BMI, physical activity |
Nabi et al. 2005e (case–control) |
Bangladesh (Chapainowabganj) arsenicosis cases, n = 235 ♂♀ |
Glucose, blood |
2.95 (95% CI: 0.954, 9.279) OR |
218.1 vs. 11.3 (mean) µg As/L drinking water Cohort: 218.1 (3–875) µg
As/L; mean (range) |
Unadjusted |
Rahman et al. 1998f (cross-sectional) |
Bangladesh (Dhaka) keratosis cases, n = 1,107 ♂♀ |
Self-report, OGTT, glucosuria |
5.2 (95% CI: 2.5, 10.5) adjPR |
Keratosis vs. non-keratosis Cohort: < 10–2,100 µg As/L |
Age |
Rahman et al. 1999f (cross-sectional) |
Bangladesh (multisite) with skin lesions, n = 430 ♂♀ |
Glucosuria |
2.9 (95% CI: 1.6, 5.2) adjPR |
> 10 vs. < 1 mg-year As/L drinking water, CEI Cohort: < 500 to
> 1,000 µg As/L drinking water |
Age, sex, BMI |
Tsai et al. 1999e (retrospective) |
Taiwan (Chiayi County) Blackfoot region, n = 19,536 deaths ♂♀ |
Death certificate |
1.46 (95% CI: 1.28, 1.67) SMR |
Blackfoot endemic region vs. national reference Cohort: 780 (250–1,140)
µg As/L; median (range) |
Age, sex |
Tseng et al. 2000a, 2000b (prospective) |
Taiwan (southwestern) agricultural and aquacultural regions, n = 446
♂♀ |
Fasting blood glucose, OGTT |
2.1 (95% CI: 1.1, 4.2) RR |
≥ 17 vs. < 17 mg/L-year As (drinking water, CEI) Cohort: 700–930 µg
As/L; range of median concentration in artesian wells |
Age, sex, BMI |
Wang SL et al. 2003g (cross-sectional) |
Taiwan (southwestern) As-endemic region, n = 706,314 ♂♀ |
Insurance claims |
2.69 (95% CI: 2.65, 2.73) adjOR |
Endemic vs. non-endemic region Cohort: 780 (350–1,140) µg As/L; median
(range)d |
Age, sex |
Abbreviations: adjOR, adjusted odds ratio; adjPR, adjusted
prevalence ratio; As, arsenic; BMI, body mass index; CEI, cumulative
exposure index; HEALS, Health Effects of Arsenic Longitudinal Study;
mg-year, milligram year; OGTT, oral glucose tolerance test; OR, odds
ratio; Q, quintile; RR, relative risk; SMR, standardized mortality
ratio. aIdentification of main findings was based on the following
strategy: for studies that did not report a significant association
between arsenic exposure and a health outcome at any exposure level, the
main summary finding was based on the highest exposure group compared to
the referent group (e.g., 4th quartile vs. 1st quartile). When a study
reported a significant association between arsenic exposure and a health
outcome, the main finding was based on lowest exposure group where a
statistically significant association was observed (e.g., 3rd quartile
vs. 1st quartile). bUnless specified, relative risk estimates are crude
estimates. cMedian or mean and range of As concentration in drinking
water for the cohort is included when reported. dArsenic drinking-water
concentrations were taken from other publications based on same
populations. eCalculated by entering data presented in publication into
OpenEpi software (Dean et al. 2011). fAlthough the arsenic water
concentrations are expressed in units of mg/L, the value is supposed to
represent the “approximate time-weighted mean arsenic exposure levels
that were calculated over the lifetime of each subject as ∑j(ajcj/∑jaj,
where aj is the number of years a well with arsenic concentration cj was
used, assuming that the current levels of arsenic in the well water were
also representative of the past source.” gThere appears to be an error
in the number of persons included in the “non-endemic” area category
based on the ns provided in Table 1 of Wang et al. 2003. |